Literature DB >> 30190865

The digital age of melanoma management: detection and diagnostics.

Alexander L Fogel1,1, Kavita Sarin2,2.   

Abstract

New technologies are increasingly impacting the way melanoma is detected and diagnosed. Devices, software and diagnostics abound, ranging from smartphone applications that purport to predict which lesions are likely to be malignant, to genomic analysis of low-stage melanomas to predict metastatic risk. The purpose of this review is to concisely update practitioners on the research behind the latest tools available for melanoma detection and diagnosis, as well as the implications of these technologies for melanoma management.

Entities:  

Keywords:  detection; diagnosis; genomics; imaging; melanoma; smartphone; teledermatology

Year:  2015        PMID: 30190865      PMCID: PMC6094706          DOI: 10.2217/mmt.15.31

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  51 in total

1.  Cost minimization analysis of a store-and-forward teledermatology consult system.

Authors:  Hon S Pak; Santanu K Datta; Crystal A Triplett; Jennifer H Lindquist; Steven C Grambow; John D Whited
Journal:  Telemed J E Health       Date:  2009-03       Impact factor: 3.536

2.  An agenda for personalized medicine.

Authors:  Pauline C Ng; Sarah S Murray; Samuel Levy; J Craig Venter
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

3.  23andMe and the FDA.

Authors:  George J Annas; Sherman Elias
Journal:  N Engl J Med       Date:  2014-02-12       Impact factor: 91.245

4.  Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection.

Authors:  R G Roetzheim; N Pal; D J van Durme; D Wathington; J M Ferrante; E C Gonzalez; J P Krischer
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

5.  Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions.

Authors:  S W Menzies; A Gutenev; M Avramidis; A Batrac; W H McCarthy
Journal:  Arch Dermatol       Date:  2001-12

6.  Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.

Authors:  Lorenzo Cerroni; Raymond Barnhill; David Elder; Geoffrey Gottlieb; Peter Heenan; Heinz Kutzner; Philip E LeBoit; Martin Mihm; Juan Rosai; Helmut Kerl
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

7.  Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.

Authors:  B Aika Shoo; Richard W Sagebiel; Mohammed Kashani-Sabet
Journal:  J Am Acad Dermatol       Date:  2010-03-19       Impact factor: 11.527

8.  The performance of MelaFind: a prospective multicenter study.

Authors:  Gary Monheit; Armand B Cognetta; Laura Ferris; Harold Rabinovitz; Kenneth Gross; Mary Martini; James M Grichnik; Martin Mihm; Victor G Prieto; Paul Googe; Roy King; Alicia Toledano; Nikolai Kabelev; Maciej Wojton; Dina Gutkowicz-Krusin
Journal:  Arch Dermatol       Date:  2010-10-18

9.  The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions.

Authors:  F Nachbar; W Stolz; T Merkle; A B Cognetta; T Vogt; M Landthaler; P Bilek; O Braun-Falco; G Plewig
Journal:  J Am Acad Dermatol       Date:  1994-04       Impact factor: 11.527

10.  A gene signature to determine metastatic behavior in thymomas.

Authors:  Yesim Gökmen-Polar; Robert W Cook; Chirayu Pankaj Goswami; Jeff Wilkinson; Derek Maetzold; John F Stone; Kristen M Oelschlager; Ioan Tudor Vladislav; Kristen L Shirar; Kenneth A Kesler; Patrick J Loehrer; Sunil Badve
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.